Bellevue Group AG Has $51.80 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Bellevue Group AG increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 16.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,654,878 shares of the company's stock after purchasing an additional 237,999 shares during the quarter. Bellevue Group AG owned 0.97% of Option Care Health worth $51,798,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. UMB Bank n.a. lifted its position in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after buying an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock valued at $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC raised its stake in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after buying an additional 2,757 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after buying an additional 377 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on OPCH shares. Truist Financial lowered their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America cut shares of Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and decreased their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Barrington Research cut their price objective on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $30.83.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by insiders.

Option Care Health Trading Up 0.2 %

Shares of OPCH traded up $0.04 during midday trading on Friday, hitting $23.80. The stock had a trading volume of 792,369 shares, compared to its average volume of 2,604,906. The business has a 50-day simple moving average of $26.84 and a two-hundred day simple moving average of $28.87. The firm has a market cap of $4.05 billion, a P/E ratio of 20.00, a price-to-earnings-growth ratio of 2.46 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.